We are live on ! Find out more
PAM

Panagora Asset Management Portfolio holdings

AUM $26.7B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+3.97%
1 Year Est. Return
+36.4%
3 Year Est. Return
+128.64%
5 Year Est. Return
+186.75%
10 Year Est. Return
+733.24%
AUM
$22.4B
AUM Growth
-$130M
Cap. Flow
-$739M
Cap. Flow %
-3.31%
Top 10 Hldgs %
17.71%
Holding
2,785
New
260
Increased
734
Reduced
989
Closed
139

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$105M
2
EBAY icon
eBay
EBAY
+$79.6M
3
PYPL icon
PayPal
PYPL
+$73.1M
4
PEP icon
PepsiCo
PEP
+$61.5M
5
MET icon
MetLife
MET
+$57.4M

Sector Composition

Rank Sector Weight
1 Technology 17.95%
2 Financials 17.2%
3 Healthcare 12.33%
4 Consumer Discretionary 11.6%
5 Industrials 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPP
2451
DELISTED
Green Plains Partners LP
GPP
$5K ﹤0.01%
384
-5,897
-94% -$88.1K
ATTO
2452
DELISTED
Atento S.A.
ATTO
$5K ﹤0.01%
423
-2,114
-83% -$33.2K
PFBI
2453
DELISTED
Premier Financial Bancorp
PFBI
$5K ﹤0.01%
+321
New +$5.16K
LOACW
2454
DELISTED
Longevity Acquisition Corporation Warrant
LOACW
$5K ﹤0.01%
33,197
GRSHW
2455
DELISTED
Gores Holdings III, Inc. Warrants
GRSHW
$5K ﹤0.01%
3,333
ICON
2456
DELISTED
Iconix Brand Group, Inc.
ICON
$5K ﹤0.01%
6,082
-2,774
-31% -$3.42K
WPG
2457
DELISTED
Washington Prime Group Inc.
WPG
$5K ﹤0.01%
140
ATEA
2458
DELISTED
ASTEA INTERNATIONAL INC
ATEA
$5K ﹤0.01%
923
BBT
2459
Beacon Financial Corp
BBT
$2.69B
$4K ﹤0.01%
+112
New +$3.34K
CLDX icon
2460
Celldex Therapeutics
CLDX
$2.96B
$4K ﹤0.01%
1,673
-5,017
-75% -$17K
CPHC icon
2461
Canterbury Park Holding Corp
CPHC
$78.8M
$4K ﹤0.01%
321
-58
-15% -$798
CSTE icon
2462
Caesarstone
CSTE
$75.4M
$4K ﹤0.01%
237
CTRN icon
2463
Citi Trends
CTRN
$582M
$4K ﹤0.01%
251
ELDN icon
2464
Eledon Pharmaceuticals
ELDN
$265M
$4K ﹤0.01%
224
-40
-15% -$1.75K
IIIV icon
2465
i3 Verticals
IIIV
$418M
$4K ﹤0.01%
122
KAI icon
2466
Kadant
KAI
$3.83B
$4K ﹤0.01%
44
-1,843
-98% -$166K
MPU icon
2467
Mega Matrix
MPU
$16.4M
$4K ﹤0.01%
2,640
-3,000
-53% -$5.67K
PCB icon
2468
PCB Bancorp
PCB
$394M
$4K ﹤0.01%
+259
New +$4.53K
PRIM icon
2469
Primoris Services
PRIM
$4.77B
$4K ﹤0.01%
195
STRL icon
2470
Sterling Infrastructure
STRL
$18.8B
$4K ﹤0.01%
329
-64,673
-99% -$833K
XBIO icon
2471
Xenetic Biosciences
XBIO
$6.09M
$4K ﹤0.01%
34
-102
-75% -$13.5K
ENZ
2472
DELISTED
Enzo Biochem, Inc.
ENZ
$4K ﹤0.01%
1,312
-5,381
-80% -$19K
RAD
2473
DELISTED
Rite Aid Corporation
RAD
$4K ﹤0.01%
437
-1
-0.2% -$9
VNTR
2474
DELISTED
Venator Materials PLC
VNTR
$4K ﹤0.01%
776
-4,518
-85% -$24.7K
BBQ
2475
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$4K ﹤0.01%
819
-76
-8% -$362

Similar funds

Panagora Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Panagora Asset Management held 2,785 positions worth $22.4B, down 0.58% from $22.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Panagora Asset Management withdrew a net $739M in Q2 2019, closing 139 positions and reducing 989 holdings. Its most notable exit was iShares MSCI Hong Kong ETF, an estimated $46.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Panagora Asset Management opened a new position in First Bancorp worth $18.2M.

  • Panagora Asset Management's largest Q2 2019 buy was First Bancorp: 1,652,706 shares worth $18.2M.
  • Panagora Asset Management added most to AbbVie in Q2 2019, an estimated $105M increase.
  • Panagora Asset Management's biggest Q2 2019 reduction was Amgen, cutting an estimated $78.7M.
  • Panagora Asset Management fully exited iShares MSCI Hong Kong ETF in Q2 2019, selling an estimated $46.3M.
  • Panagora Asset Management's ten largest holdings make up 18% of its $22.4B portfolio in Q2 2019.
  • Panagora Asset Management opened 260 new positions and closed 139 in Q2 2019.
  • Panagora Asset Management's portfolio value fell 0.58% quarter-over-quarter to $22.4B.

Based on Panagora Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.